Skip to main content
. 2014 Aug 28;20(32):11400–11405. doi: 10.3748/wjg.v20.i32.11400

Figure 1.

Figure 1

Overall efficacy of 15 mg/d tolvaptan. Overall efficacy of 15 mg/d tolvaptan for 5-14 d in all patients as well as in subgroups of patients with coexisting hepatocellular carcinoma (HCC) and hepatorenal syndrome (HRS) post-tolvaptan treatment.